PDS Biotechnology Corp
NASDAQ:PDSB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PDS Biotechnology Corp
NASDAQ:PDSB
|
US |
|
B
|
Barclays PLC
F:BCY
|
UK |
|
BAE Systems PLC
OTC:BAESF
|
UK |
|
Z
|
Zurich Insurance Group AG
XHAM:ZFIN
|
CH |
|
L
|
Lenovo Group Ltd
OTC:LNVGF
|
CN |
|
Steadfast Group Ltd
ASX:SDF
|
AU |
|
C
|
CNOOC Ltd
SSE:600938
|
CN |
|
E
|
Encompass Health Corp
SWB:HSOA
|
US |
|
M
|
Marsh & McLennan Companies Inc
SWB:MSN
|
US |
|
C
|
Canadian Imperial Bank of Commerce
SWB:CAI
|
CA |
|
D
|
Dominion Energy Inc
DUS:DOD
|
US |
|
O
|
Oracle Corp
SWB:ORC
|
US |
|
H
|
Hon Hai Precision Industry Co Ltd
SWB:HHP2
|
TW |
|
E
|
Encompass Health Corp
F:HSOA
|
US |
|
Freeport-McMoRan Inc
NYSE:FCX
|
US |
|
I
|
Inter Pharma PCL
SET:IP
|
TH |
|
Trade Desk Inc
BMV:TTD
|
US |
Wall St Price Targets
PDSB Price Targets Summary
PDS Biotechnology Corp
According to Wall Street analysts, the average 1-year price target for
PDSB is 7.65 USD with a low forecast of 3.03 USD and a high forecast of 15.75 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PDSB's stock price target?
Price Target
7.65
USD
According to Wall Street analysts, the average 1-year price target for
PDSB is 7.65 USD with a low forecast of 3.03 USD and a high forecast of 15.75 USD.